MedTrace Logo

COVID-19 - Cytokine Storm

NCT04474067 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-12-22

No results posted yet for this study

Summary

This is a multi-center study comparing clinical outcomes in patients with COVID-19 in subjects hospitalized at Hadassah and other hospitals for PCR or serology confirmed COVID-19 and compare the outcomes to the presence of different degrees of a cytokine storm. The patients will be subdivided into a mild, moderate, and severe course according to NEWS2.

Conditions

Interventions

OTHER

No intervention

This is an observational study, with no intervention.

Sponsors & Collaborators

  • Barzilai Medical Center

    collaborator OTHER

  • The Chaim Sheba Medical Center

    collaborator OTHER

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Dror Mevorach, MD · Hadassah Medical Organization

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-28
Primary Completion
2021-03-31
Completion
2021-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04474067 on ClinicalTrials.gov